In the US, Avastin (bevacizumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Colorectal Cancer, Glioblastoma Multiforme, Macular Degeneration, Malignant Glioma, Neurofibromatosis, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Renal Cell Carcinoma and Solid Tumors.
US matches:
- Avastin
- Avastin Solution
UK matches:
- Avastin 25mg/ml concentrate for solution for infusion (SPC)
Ingredient matches for Avastin
Bevacizumab
Bevacizumab is reported as an ingredient of Avastin in the following countries:
- Algeria
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Bosnia & Herzegowina
- Bulgaria
- Canada
- Chile
- Colombia
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Egypt
- Finland
- France
- Georgia
- Germany
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jordan
- Kuwait
- Lebanon
- Luxembourg
- Mexico
- Netherlands
- New Zealand
- Norway
- Oman
- Philippines
- Portugal
- Qatar
- Romania
- Russian Federation
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Switzerland
- Syria
- Taiwan
- Thailand
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Yemen
Simvastatin
Simvastatin is reported as an ingredient of Avastin in the following countries:
- Bangladesh
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment